Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode

被引:35
作者
Meyers, Marvin J. [1 ]
Pelc, Matthew [1 ]
Kamtekar, Satwik [1 ]
Day, Jacqueline [1 ]
Poda, Gennadiy I. [1 ]
Hall, Molly K. [1 ]
Michener, Marshall L. [1 ]
Reitz, Beverly A. [1 ]
Mathis, Karl J. [1 ]
Pierce, Betsy S. [1 ]
Parikh, Mihir D. [1 ]
Mischke, Deborah A. [1 ]
Long, Scott A. [1 ]
Parlow, John J. [1 ]
Anderson, David R. [1 ]
Thorarensen, Atli [1 ]
机构
[1] Pfizer Global Res & Dev, St Louis Labs, Chesterfield, MO 63017 USA
关键词
cFMS; CSF-1R; Kinase; DFG-in; DFG-out; Structure-based drug design; BIOCHEMICAL-MECHANISMS; CFMS; EFFICIENCY; MACROPHAGE; DISCOVERY;
D O I
10.1016/j.bmcl.2010.01.078
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The work described herein demonstrates the utility of structure-based drug design (SBDD) in shifting the binding mode of an HTS hit from a DFG-in to a DFG-out binding mode resulting in a class of novel potent CSF-1R kinase inhibitors suitable for lead development. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1543 / 1547
页数:5
相关论文
共 28 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl) oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats [J].
Conway, James G. ;
Pink, Heather ;
Bergquist, Mandy L. ;
Han, Bajin ;
Depee, Scott ;
Tadepalli, Sarva ;
Lin, Peiyuan ;
Crumrine, R. Christian ;
Binz, Jane ;
Clark, Richard L. ;
Selph, Jeffrey L. ;
Stimpson, Stephen A. ;
Hutchins, Jeff T. ;
Chamberlain, Stanley D. ;
Brodie, Thomas A. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 326 (01) :41-50
[3]   Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580 [J].
Conway, JG ;
McDonald, B ;
Parham, J ;
Keith, B ;
Rusnak, DW ;
Shaw, E ;
Jansen, M ;
Lin, PY ;
Payne, A ;
Crosby, RM ;
Johnson, JH ;
Frick, L ;
Lin, MHJ ;
Depee, S ;
Tadepalli, S ;
Votta, B ;
James, I ;
Fuller, K ;
Chambers, TJ ;
Kull, FC ;
Chamberlain, SD ;
Hutchins, JT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (44) :16078-16083
[4]  
EMERSON HK, 2009, Patent No. 7491731
[5]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[6]   Ligand efficiency: a useful metric for lead selection [J].
Hopkins, AL ;
Groom, CR ;
Alex, A .
DRUG DISCOVERY TODAY, 2004, 9 (10) :430-431
[7]   Pyrido[2,3-d]pyrimidin-5-ones: A Novel Class of Antiinflammatory Macrophage Colony-Stimulating Factor-1 Receptor Inhibitors [J].
Huang, Hui ;
Hutta, Daniel A. ;
Rinker, James M. ;
Hu, Huaping ;
Parsons, William H. ;
Schubert, Carsten ;
DesJarlais, Renee L. ;
Crysler, Carl S. ;
Chaikin, Margery A. ;
Donatelli, Robert R. ;
Chen, Yanmin ;
Cheng, Deping ;
Zhou, Zhao ;
Yurkow, Edward ;
Manthey, Carl L. ;
Player, Mark R. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (04) :1081-1099
[8]   Discovery of novel FMS kinase inhibitors as anti-inflammatory agents [J].
Illig, Carl R. ;
Chen, Jinsheng ;
Wall, Mark J. ;
Wilson, Kenneth J. ;
Ballentine, Shelley K. ;
Rudolph, M. Jonathan ;
DesJarlais, Renee L. ;
Chen, Yanmin ;
Schubert, Carsten ;
Petrounia, Ioanna ;
Crysler, Carl S. ;
Molloy, Christopher J. ;
Chaikin, Margery A. ;
Manthey, Carl L. ;
Player, Mark R. ;
Tomczuk, Bruce E. ;
Meegalla, Sanath K. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (05) :1642-1648
[9]   QT interval prolongation: And the beat goes on [J].
Jalaie, M ;
Holsworth, DD .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (12) :1083-1091
[10]   Medicinal chemistry of hERG optimizations: Highlights and hang-ups [J].
Jamieson, Craig ;
Moir, Elizabeth M. ;
Rankovic, Zoran ;
Wishart, Grant .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (17) :5029-5046